Harley Street planning permission granted
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at a meeting held yesterday at Westminster City Council, planning permission for the Harley Street site was granted.
Commenting, Dr. Michael Sinclair, Executive Chairman and CEO of Advanced Oncotherapy, said: “The Harley Street Proton facility will make an important contribution to the advancement of next generation radiotherapy in the UK, and add even further lustre to the international reputation of the Howard de Walden Estate and the Harley Street Medical Area. Now that we are in a position to continue with the development, our partner, Howard de Walden Estates, plans to start work on the site as soon as possible. During the construction period every effort will be made to ensure minimal inconvenience to local residents.“
Simon Baynham, Property Director of Howard de Walden Estates, commented: “The Estate is delighted that this new ground breaking technology will be coming to The Harley Street Medical Area. From a personal point of view I know many people who would have benefited from this new technology had it been available previously. Accordingly the sooner we get on and build it, the better.”
Advanced Oncotherapy Plc |
|
Dr. Michael Sinclair, Executive Chairman & CEO |
Tel: +44 20 3617 8728 |
Nicolas Serandour, CFO & COO |
|
|
|
Stockdale Securities (Nomad & Joint Broker) |
|
Antonio Bossi / David Coaten |
Tel: +44 20 7601 6100 |
|
|
Beaufort Securities (Joint Broker) |
|
Jon Belliss / Elliot Hance |
Tel: +44 20 7382 8300 |
|
|
Walbrook PR (Financial PR & IR) |
Tel: +44 20 7933 8780 or avo@walbrookpr.com |
Paul McManus / Anna Dunphy |
Mob: +44 7980 541 893 / Mob: +44 7876 741 001 |